Nano Labs (NA) Cash & Equivalents (2021 - 2026)

Nano Labs has reported Cash & Equivalents for 5 years, with the latest figure at $1.2 million in Q4 2025.

• Quarterly Cash & Equivalents fell 73.45% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 73.45% YoY) and the FY2025 annual result came in at $1.2 million, down 73.19% from the prior year.
• Cash & Equivalents declined to $1.2 million in Q4 2025 per NA's latest filing, from $50.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $50.8 million in Q2 2025 and troughed at $7.02 in Q3 2024.
• A 5-year average of $9.2 million and a median of $4.5 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents jumped 89023.71% in 2022, then tumbled 73.45% in 2025.
• Over 5 years, Cash & Equivalents stood at $13853.4 in 2021, then surged by 89023.71% to $12.3 million in 2022, then sank by 45.82% to $6.7 million in 2023, then sank by 32.51% to $4.5 million in 2024, then sank by 73.45% to $1.2 million in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $1.2 million, $50.8 million, and $4.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.